FDA Drug Topics: How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety – October 19, 2021
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, October 19, 2021, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety. This webinar described the role of the FDA Division of Medication Error Prevention and Analysis (DMEPA) in preventing and addressing medication errors through pre-market and post-market activities. DMEPA collaborates with the nonprofit Institute for Safe Medication Practices (ISMP), to share information from the ISMP National Medication Errors Reporting Program in a way that benefits overall drug safety. Actions taken to address recent medication error reports were explored, and the role of health care practitioners in identifying, preventing, and mitigating medication errors were discussed.
View Presentation Here: https://collaboration.fda.gov/pub5nmuvz9t1/
Download Presentation Slides: How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety (PDF - 8MB)
Activity Outline and Continuing Education Information: How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety (PDF - 157KB)
If you have never attended an Adobe Connect meeting before (Google Chrome (preferred) or Firefox 43 or higher):
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.